IP Library Assignment 040723/0170
Patent Assignment
Reel/Frame 040723/0170

Assignment of Assignor's Interest

Recorded: 2016-12-13 Pages: 2
Assignor
CAMBREX KARLSKOGA AB
Executed: 2016-10-20
Assignee
CAMBREX CHARLES CITY, INC.
1205 11TH STREET, CHARLES CITY, IOWA, 50616
Covered Property (1)
Preparation of Saturated Ketone Morphinan Compounds by Catalytic Isomerisation
Patent: 9,981,978 →
Application: 14/906,776 →
Publication: US 2016/0168159
Related Assignments (9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 12, 2016
From: TRACEY, MICHAEL; HOLMBERG, PÄR
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 038249/0545 →
Assignment of Assignor's Interest Dec 9, 2016
From: MATUTE, BELÉN LINDBERG MARTIN; GÓMEZ, ANTONIO BERMEJO; BÄCKVALL, JAN-ERLING
To: STOCKHOLMS UNIVERSITET HOLDING AB OF STOCKHOLM UNIVERSITY
Reel/Frame 040699/0975 →
Assignment of Assignor's Interest Dec 12, 2016
From: STOCKHOLMS UNIVERSITET HOLDING AB OF STOCKHOLM UNIVERSITY
To: CAMBREX KARLSKOGA AB
Reel/Frame 040708/0988 →
Security Interest Jan 3, 2019
From: CAMBREX CHARLES CITY, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 047895/0053 →
Notice of Release of Security Interest in Patents Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 051283/0903 →
Second Lien Patent Security Agreement Dec 4, 2019
From: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051196/0080 →
First Lien Patent Security Agreement Dec 4, 2019
From: AVISTA PHARMA SOLUTIONS, INC.; CAMBREX CHARLES CITY, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051283/0877 →
Release of Second Lien Security Interest in Patents Dec 7, 2020
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 054630/0307 →
Release of First Lien Security Interest in Patents Mar 6, 2025
From: ROYAL BANK OF CANADA
To: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.; SNAPDRAGON CHEMISTRY, INC.
Reel/Frame 070438/0333 →